Item 5.07 Submission of Matters to a Vote of Security Holders (a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 27, 2023. (b) Shareholders voted on the matters set forth below.



1. The nominees for election to the Company's Board of Directors set forth in Item 1 to the Company's Proxy Statement filed with the U.S. Securities and
Exchange Commission on March 16, 2023 were elected to hold office until the Company's next Annual Meeting of Shareholders, based upon the following
votes:

Nominee                                              Votes For             Votes Against                 Abstentions            Broker non-vote
Ronald E. Blaylock                               3,789,612,837                83,839,363                  12,467,881                822,779,764
Albert Bourla                                    3,653,674,437               208,682,127                  23,564,504                822,779,764
Susan Desmond-Hellmann                           3,828,773,799                46,025,527                  11,121,794                822,779,764
Joseph J. Echevarria                             3,778,999,117                94,432,165                  12,489,838                822,779,764
Scott Gottlieb                                   3,842,319,407                32,995,098                  10,606,615                822,779,764
Helen H. Hobbs                                   3,785,122,522                89,855,218                  10,943,380                822,779,764
Susan Hockfield                                  3,844,758,007                29,938,558                  11,222,555                822,779,764
Dan R. Littman                                   3,820,810,803                52,740,318                  12,369,605                822,779,764
Shantanu Narayen                                 3,834,990,965                38,626,491                  12,303,663                822,779,764
Suzanne Nora Johnson                             3,647,540,160               226,795,872                  11,585,088                822,779,764
James Quincey                                    3,793,804,997                79,619,976                  12,495,108                822,779,764
James C. Smith                                   3,759,605,435               114,075,438                  12,240,247                822,779,764




2. The proposal to ratify the selection of KPMG LLP as the Company's independent registered public
accounting firm for the 2023 fiscal year was approved based upon the following votes:

Votes for approval                           4,476,884,380
Votes against                                  216,080,165
Abstentions                                     15,730,121
Broker non-votes                                       n/a

3. The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:



Votes for approval                           3,579,314,991
Votes against                                  278,786,983
Abstentions                                     27,817,386
Broker non-votes                               822,779,764

--------------------------------------------------------------------------------

4. The proposal on the advisory vote on the frequency of future advisory votes to approve executive compensation received the following votes:



For 1 year                                       3,766,703,452
For 2 years                                         14,391,226
For 3 years                                         89,089,799
Abstentions                                         15,686,294
Broker non-votes                                   822,779,764

5. The shareholder proposal regarding ratification of termination pay was not approved based upon the
following votes:
Votes for approval                                 383,373,901
Votes against                                    3,471,502,220
Abstentions                                         31,042,621
Broker non-votes                                   822,779,764



6. The shareholder proposal regarding independent board chairman policy was not approved based upon the following
votes:

Votes for approval                                   1,341,494,540
Votes against                                        2,522,043,083
Abstentions                                             22,383,108
Broker non-votes                                       822,779,764


7. The shareholder proposal regarding transfer of intellectual property to potential COVID-19
manufacturers feasibility report was not approved based upon the following votes:

Votes for approval                           466,014,359
Votes against                              3,345,078,090
Abstentions                                   74,828,282
Broker non-votes                             822,779,764

8. The shareholder proposal regarding impact of extended patent exclusivities on product access report
was not approved based upon the following votes:
Votes for approval                         1,152,896,529
Votes against                              2,665,474,921
Abstentions                                   67,549,520
Broker non-votes                             822,779,764

9. The shareholder proposal regarding political contributions congruency report was not approved based
upon the following votes:
Votes for approval                           539,212,248
Votes against                              3,275,597,231
Abstentions                                   71,110,795
Broker non-votes                             822,779,764


(c) Not applicable.
(d) Based upon the results set forth in item (b) (4) above, and consistent with the
Board's recommendation, the Board of Directors has determined that advisory votes on
executive compensation will be submitted to shareholders on an annual basis until the next
required vote on the frequency of such votes.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses